RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 75 filers reported holding RELMADA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $719,905 | +24.9% | 239,904 | +2.4% | 0.00% | – |
Q2 2023 | $576,530 | -49.2% | 234,362 | -53.3% | 0.00% | – |
Q1 2023 | $1,135,295 | +66800.1% | 502,343 | +3.3% | 0.00% | – |
Q4 2022 | $1,697 | -100.0% | 486,251 | -0.9% | 0.00% | -100.0% |
Q3 2022 | $18,169,000 | +92.4% | 490,812 | -1.3% | 0.00% | +200.0% |
Q2 2022 | $9,444,000 | -23.1% | 497,327 | +9.3% | 0.00% | -50.0% |
Q1 2022 | $12,277,000 | +58.4% | 454,904 | +32.3% | 0.00% | +100.0% |
Q4 2021 | $7,749,000 | +16.5% | 343,957 | +35.6% | 0.00% | 0.0% |
Q3 2021 | $6,649,000 | -15.0% | 253,703 | +3.8% | 0.00% | 0.0% |
Q2 2021 | $7,821,000 | -7.2% | 244,332 | +2.1% | 0.00% | 0.0% |
Q1 2021 | $8,424,000 | +27.7% | 239,272 | +16.3% | 0.00% | 0.0% |
Q4 2020 | $6,596,000 | -12.4% | 205,687 | +2.7% | 0.00% | 0.0% |
Q3 2020 | $7,533,000 | -15.1% | 200,250 | +1.0% | 0.00% | -50.0% |
Q2 2020 | $8,871,000 | +141.5% | 198,243 | +84.1% | 0.00% | +100.0% |
Q1 2020 | $3,673,000 | -51.5% | 107,689 | -44.6% | 0.00% | 0.0% |
Q4 2019 | $7,574,000 | – | 194,216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |